KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 163 filers reported holding KARUNA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,585,615 | +19.4% | 16,535 | 0.0% | 0.02% | +16.7% |
| Q1 2023 | $3,003,417 | -25.6% | 16,535 | -19.5% | 0.02% | -25.0% |
| Q4 2022 | $4,038,075 | -56.3% | 20,550 | -50.0% | 0.02% | -56.4% |
| Q3 2022 | $9,244,173 | +488.4% | 41,098 | +220.0% | 0.06% | +1000.0% |
| Q3 2021 | $1,571,000 | +7.3% | 12,844 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $1,464,000 | +89.6% | 12,844 | +100.0% | 0.01% | +66.7% |
| Q1 2021 | $772,000 | – | 6,422 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |